Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Oct 13:9:1026202.
doi: 10.3389/fmed.2022.1026202. eCollection 2022.

Editorial: Molecular mechanisms of proteinuria, volume II

Ilse S Daehn  1 , Sandra Merscher  2
Affiliations
Editorial

Editorial: Molecular mechanisms of proteinuria, volume II

Ilse S Daehn et al. Front Med (Lausanne). .
No abstract available

Keywords: glomerulus; kidney disease; mechanisms of disease; models of disease; proteinuria.

PubMed Disclaimer

Conflict of interest statement

SM is an inventor on pending or issued patents (PCT/US11/56272, PCT/US12/62594, PCT/US2019/041730, PCT/US2019/032215, PCT/US13/36484, and PCT 62/674,897) aimed at diagnosing or treating proteinuric kidney diseases and stands to gain royalties from the future commercialization of these patents. SM holds equity interest in L&F Research who has licensed worldwide rights to develop and commercialize hydroxypropyl-beta-cyclodextrin to ZyVersa Therapeutics, Inc. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Molecular mechanisms of proteinuria, volume II

Similar articles

See all similar articles

References

    1. Heerspink HJ, Greene T, Tighiouart H, Gansevoort RT, Coresh J, Simon AL, et al. . Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials. Lancet Diabetes Endocrinol. (2019) 7:128–39. 10.1016/S2213-8587(18)30314-0 - DOI - PubMed
    1. Coresh J, Heerspink HJ, Sang Y, Matsushita K, Arnlov J, Astor BC, et al. . Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies. Lancet Diabetes Endocrinol. (2019) 7:115–27. 10.1016/S2213-8587(18)30313-9 - DOI - PMC - PubMed
    1. Guéry B, Choukroun G, Noël LH, Clavel P, Rötig A, Lebon S, et al. . The spectrum of systemic involvement in adults presenting with renal lesion and mitochondrial tRNA(Leu) gene mutation. J Am Soc Nephrol. (2003) 14:2099–108. 10.1097/01.ASN.0000080180.51098.02 - DOI - PubMed
    1. Chen A, Yin L, Lee K, He JC. Similarities and differences between COVID-19-associated nephropathy and HIV-associated nephropathy. Kidney Dis. (2022) 8:1–12. 10.1159/000520235 - DOI - PMC - PubMed
    1. Daehn IS, Duffield JS. The glomerular filtration barrier: a structural target for novel kidney therapies. Nat Rev Drug Discov. (2021) 20:770–88. 10.1038/s41573-021-00242-0 - DOI - PMC - PubMed

Publication types

LinkOut - more resources